DC Field | Value | Language |
dc.contributor.author | Frasineac, Veronica | - |
dc.contributor.author | Arian, Iurii | - |
dc.date.accessioned | 2020-10-19T07:45:23Z | - |
dc.date.available | 2020-10-19T07:45:23Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | FRASINEAC, Veronica, ARIAN, Iurii. Comparative epidemiology and resistance trends of common urinary pathogens. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 82-83. | en_US |
dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/12222 | - |
dc.description | Department of Urology and Surgical Nephrology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020 | en_US |
dc.description.abstract | Introduction. Urinary tract infections (UTIs) are some of the most common infections in
human medicine, affecting a large patient population (around 150 million cases/year) to various
extents, irrespective of age and gender. The principal cause of UTIs (>80%) are uropathogenic
Escherichia coli and Klebsiella species both in the community and nosocomial settings. The
assessment of local data on the prevalence and resistance is essential to evaluate trends over
time and to make adjustments on the empirical treatment protocol.
Aim of the study. Assessment of epidemiology and resistance trends of most common urinary
pathogens in order to create a hospital-specific antibiogram and practical recommendation on
first chose antibiotics for empirical and prevention treatment.Materials and methods.. A retrospective record review of data collected from laboratory
results of 1299 patients admitted to the Urology Department of Republican Clinical Hospital
between April 2019 and October 2019 was done. The outcome of interest was the antibiotic
susceptibility of bacterial isolates from the patient’s urine probes, before or after planned
surgery. Pathogens the selection was done according to the highest incidence observed:
Escherichia Coli, Klebsiella pneumonia, Proteus Mirabilis and Pseudomonas aeruginosa. The
isolates were analyzed for susceptibility and resistance to 4 antimicrobial groups
(Cephalosporins, Carbapenems, Fluoroquinolones, Aminoglycosides) and 3 miscellaneous
agents (Nitrofurantoin, Fosfomycin trometamol, Trimethoprim-sulfamethoxazole).
Results. A total of 221 (17%) isolates from urines, of 4 selected bacteria were analyzed:
Escherichia Coli (43.43%), Klebsiella pneumonia (33,48%), Proteus Mirabilis (12.66%) and
Pseudomonas aeruginosa (5.88%). According to received data, the highest susceptibility for
Escherichia Coli, Klebsiella pneumonia and Proteus Mirabilis it was for Fosfomycin with
92.7%, 63.51% and 89.28 respectively. Pseudomonas aeruginosa sensitivity it was highest for
Amikacin followed by Carbapenems and Cefalosporins with 76.92%, 61.53% and 53.84%
respectively. Klebsiella pneumonia was found with the lowest susceptibility to Cephalosporins
(29.72%), Fluoroquinolones (27.02%) and Nitrofurantoin (18.91%) – those antibiotics that are
most commonly used as prophylaxis and empirical treatment. If we consider the general impact
of Amikacin on selected bacteria, we see that almost 75% of all isolates are sensitive to it.
Conclusions. Statistically significant increases in resistance to commonly used antibiotics
were observed. In this respect, we consider that the choice of empiric antibiotic therapy should
be selected based on local susceptibility profiles. The choice of antimicrobial drugs should be
reconsidered when it comes to prevention or empiric treatment, as most commonly used groups
of antibiotics are no more effective. From this specific study, we can conclude that Amikacin
and Fosfomycin trometamol should be considered as first chose antibiotics for empirical and
prevention treatment. | en_US |
dc.language.iso | en | en_US |
dc.publisher | MedEspera | en_US |
dc.subject | urinary tract infection | en_US |
dc.subject | antibiotics | en_US |
dc.subject | resistance | en_US |
dc.subject | epidemiology | en_US |
dc.subject | fosfomycin | en_US |
dc.subject | amikacin | en_US |
dc.subject | Escherichia coli | en_US |
dc.subject | Klebsiella pneumonia | en_US |
dc.subject | Proteus Mirabilis | en_US |
dc.subject | Pseudomonas aeruginosa | en_US |
dc.title | Comparative epidemiology and resistance trends of common urinary pathogens | en_US |
dc.type | Article | en_US |
Appears in Collections: | MedEspera 2020
|